Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824/miR-4483/PD-L1 pathway
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2026.154381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Jia-Xiang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Shandong Medical and Pharmaceutical University Hospital, Binzhou, Shandong, 256603, PR China; Department of Biochemistry and Mol…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, B7-H1 Antigen, Lung Neoplasms. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Growing evidence indicates that lactate and long non-coding RNAs (lincRNAs) exert a crucial influence on tumor development. This study aimed to investigate lactate-induced histone lactylation promotes the roles of lincRNA in lung cancer progression by enhancing proliferation and PD-L1-mediated inhibition of T cell antitumor function. Results showed that both linc00824 and lactate levels were elevated in NSCLC tissues compared to adjacent controls. Lactate upregulated linc00824 expression by regulating histone H3K18 lactylation. Functioning as an oncogene, linc00824 promoted NSCLC cell proliferation and migration. Furthermore, linc00824 upregulated PD-L1 expression through targeting miR-4483 in H1975 cells, thereby suppressing CD8+ T cell activation. MiR-4483 inhibited lung cancer cell proliferation and exhibited synergistic antitumor effects with envafolimab. In summary, lactate-induced histone lactylation drives linc00824 upregulation, facilitating lung cancer progression by enhancing tumor cell proliferation and suppressing T cell antitumor function via regulating miR-4483/PD-L1. We identified an antitumor strategy for lung cancer by using miR-4483.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Department, Shandong Medical and Pharmaceutical University Hospital, Binzhou, Shandong, 256603, PR China; Department of Biochemistry and Molecular Biology, Shandong Medical and Pharmaceutical University, YanTai…
- Department of Anesthesiology, Yantai Affiliated Hospital of Shandong Medical and Pharmaceutical University, Yantai, 264000, PR China.
- Department of Biochemistry and Molecular Biology, Shandong Medical and Pharmaceutical University, YanTai, Shandong, 264003, PR China.
- The Second Medical College, Shandong Medical and Pharmaceutical University, Yantai, Shandong, 264000, PR China.
- Yantai Central Blood Station, Yantai, Shandong, 264003, PR China.
- Oncology Department, Shandong Medical and Pharmaceutical University Hospital, Binzhou, Shandong, 256603, PR China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, J. X., Qiu, J. M., Wang, N., Wu, D., Guo, Y., Li, X. Y., Yu, J. H., Li, X. H., Ning, F., Wang, P. Y., Xie, S. Y., & Xie, N. (2026). Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824/miR-4483/PD-L1 pathway. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.154381
Vancouver
Zhang JX, Qiu JM, Wang N, Wu D, Guo Y, Li XY, et al. Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824/miR-4483/PD-L1 pathway. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.154381
BibTeX
@article{Zhang2026,
author = {Zhang, Jia-Xiang and Qiu, Jun-Ming and Wang, Nana and Wu, Dongyang and Guo, Yang and Li, Xi-Yan and Yu, Jia-Hui and Li, Xiao-Hua and Ning, Fangling and Wang, Ping-Yu and Xie, Shu-Yang and Xie, Ning},
title = {Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824/miR-4483/PD-L1 pathway},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2026.154381}
}
EUVIMED